CN108059603B - Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine - Google Patents

Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine Download PDF

Info

Publication number
CN108059603B
CN108059603B CN201711475501.5A CN201711475501A CN108059603B CN 108059603 B CN108059603 B CN 108059603B CN 201711475501 A CN201711475501 A CN 201711475501A CN 108059603 B CN108059603 B CN 108059603B
Authority
CN
China
Prior art keywords
methyl
alcohol amine
elution
meoh
eluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201711475501.5A
Other languages
Chinese (zh)
Other versions
CN108059603A (en
Inventor
张富强
常森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Xinhua Pharmaceutical Co Ltd
Original Assignee
Shandong Xinhua Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Xinhua Pharmaceutical Co Ltd filed Critical Shandong Xinhua Pharmaceutical Co Ltd
Priority to CN201711475501.5A priority Critical patent/CN108059603B/en
Publication of CN108059603A publication Critical patent/CN108059603A/en
Application granted granted Critical
Publication of CN108059603B publication Critical patent/CN108059603B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine, which comprises the following two steps of separation and purification: (1) adsorbing with resin, and gradient eluting with H2O elution, MeOH/H2Elution with 20% O and pure MeOH gave H respectively2O elution MeOH/H2O ═ 20% elution and pure MeOH elution 3 eluates; (2) concentrating the pure MeOH eluent in the step (1) to obtain an N-methyl-well-sentry enzyme alcohol amine crude product, preparing a liquid phase by adopting HPLC, detecting at 210nm, eluting by using a methanol aqueous solution, separating the eluent, concentrating and freeze-drying to obtain an N-methyl-well-sentry enzyme alcohol amine pure product. The method has the advantages of simple process, high efficiency and high purity, and can obtain a pure product with the content of more than 99.9 percent from the N-methyl-Jinggang-enzyme alcohol amine crude product with the content of 30 percent by the treatment method.

Description

Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine
Technical Field
The invention relates to a refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine, belonging to the technical field of drug synthesis.
Background
Voglibose has an inhibitory effect on α -glucosidase, thereby inhibiting hydrolysis of disaccharide and delaying absorption of saccharide. Simultaneously, the medicine can relieve hypertriglyceridemia and hyperinsulinemia.
The voglibose has obvious hypoglycemic effect, the occupancy rate of the voglibose in hypoglycemic drug markets is higher and higher, and the research on the related impurities of the voglibose, such as N-methyljingganganese olamine as an impurity, needs to determine the influence of the alcohol amine on the activity of the voglibose in vivo, so the research on the impurities of the voglibose is very necessary. The invention aims to obtain more than 99.9% of N-methyl Jinggang alcohol amine impurities, so that the methodology of the N-methyl Jinggang alcohol amine impurities can be better researched, and the influence of the N-methyl Jinggang alcohol amine impurities on the metabolism of the Voglibose in the body can be further researched.
At present, no patent or literature report is published.
Disclosure of Invention
The invention aims to provide a refining process of Voglibose impurity N-methyl Jinggang alcohol amine, which has the advantages of simple process, high efficiency and high purity, and the N-methyl Jinggang alcohol amine crude product with the content of 30 percent is processed by the method to obtain a pure product with the content of more than 99.9 percent.
The refining process of the voglibose impurity N-methyl Jinggang alcohol amine comprises two steps of separation and purification:
(1) firstly using resin to adsorb, then using gradient elution to make adsorption,wherein the gradient elution process is H2O elution, MeOH/H2Elution with 20% O and pure MeOH gave H respectively2O elution MeOH/H2O ═ 20% elution and pure MeOH elution 3 eluates;
(2) concentrating the pure MeOH eluent in the step (1) to obtain an N-methyl-well-sentry enzyme alcohol amine crude product, preparing a liquid phase by adopting HPLC, detecting at 210nm, eluting by using a methanol aqueous solution, separating the eluent, concentrating and freeze-drying to obtain an N-methyl-well-sentry enzyme alcohol amine pure product.
In step (2), the eluent used for preparing the liquid phase is 5% methanol, 10% methanol or 20% methanol.
In the step (1), the resin used is small-pore resin, and the small-pore resin is one of KY2-8 type, 001 × 7 strong-acid styrene cation exchange resin or Dowex50 type.
The small-pore resin is 001 × 7 strong-acid styrene cation exchange resin.
And (2) concentrating the pure MeOH eluent in the step (1), namely washing all the residual organic matters with methanol until no organic matter remains, and concentrating the methanol to obtain the N-methylwellian enzyme alcohol amine crude product.
H2O eluent and MeOH/H2The O ═ 20% eluent was a mixture of the trimethyl substitution product quaternary ammonium salt and the dimethyl substitution product, and the pure methanol eluent was the target product N-methylvalienamine.
The first step of separation and purification:
in the first step, the quaternary ammonium salt is removed as much as possible by using a small-pore resin for separation and purification.
Adsorbing with resin, and gradient eluting to obtain H2O elution, MeOH/H2Elution with 20% O and pure MeOH gave H respectively2Eluent O, MeOH/H2And (3) concentrating the obtained pure methanol eluent to obtain a crude product of the N-methyljingganganese olamine with the purity of more than 80%.
Characterization by Nuclear magnetism H2O eluent and MeOH/H2The eluent material with 20 percent of O is mainly trimethyl substitution product quaternary ammonium saltAnd a mixture of dimethyl substitution products; the methanol eluent material is mainly the target product N-methyl valienamine.
And a second step of separation and purification:
and concentrating the methanol eluent obtained in the first step, and preparing a liquid phase to obtain a pure target product.
The eluent used for the preparation of the liquid phase here is 5% methanol, 10% methanol, 20% methanol, preferably 10% methanol.
The sugar mixture containing trimethyl substitution product quaternary ammonium salt and target product N-methyl valienamine, during the concentration treatment, the trimethyl substitution product quaternary ammonium salt is used as a good methylating agent to destroy the N-methyl valienamine into dimethyl valienamine, so that the separation yield is reduced. The method of fast column passing is used to obtain 80% content of monomethyl product, and then the pure monomethyl product is obtained by preparative liquid phase separation.
After the second step of separation and purification, the purity of the product reaches more than 99.9 percent.
The chemical equation of the invention is as follows:
Figure BDA0001532745460000021
the process firstly adopts the adsorption of a small-hole adsorption resin, and the elution gradient is set to be H2O elution, MeOH/H2And (3) performing elution by 20 percent and pure MeOH, wherein the methanol eluent is mainly the target product N-methyl valienamine and has the purity of over 80 percent. Then preparing a pure product of the target product by using a preparation liquid phase.
Compared with the prior art, the invention has the following beneficial effects:
the refining process of the voglibose impurity N-methyl Jinggang alcohol amine has the advantages of simple process, high efficiency and high purity, and can obtain a pure product with the content of more than 99.9 percent by using the N-methyl Jinggang alcohol amine crude product with the content of 30 percent through the treatment method.
Drawings
FIG. 1 is a nuclear magnetic hydrogen spectrum of N-methyl Kong enzyme alcohol amine;
FIG. 2 is a nuclear magnetic carbon spectrum of N-methyl wellsite alcohol amine;
FIG. 3 is a high resolution mass spectrum of N-methyl Kong enzyme alcohol amine.
Detailed Description
The invention is further described with reference to the following examples, which are not intended to be limiting.
Example 1
Methyl iodide is firstly used for reacting with Jinggang enzyme alcohol amine to obtain a crude product of N-methyl-Jinggang enzyme alcohol amine with the content of about 30 percent.
Taking 1g of crude product, adsorbing with 80ml of KY2-8 type resin for half an hour, and then using 100ml of H2O elution with 100ml MeOH/H2Eluting with 20% of O, then eluting with 100ml of pure MeOH, wherein the obtained pure MeOH eluent is mainly the target product N-methylvalienamine, and concentrating the obtained pure MeOH eluent to obtain the crude product of N-methyljingganganese alcohol amine with the purity of 80.22%.
And in the second step, HPLC preparation liquid phase separation is adopted, detection is carried out at 210nm, 5% methanol elution is carried out, a purer target product eluent is separated, concentration and freeze-drying are carried out, and the N-methylwellsite enzymatic hydramine with the content of 175mg of 99.51% is obtained.
Example 2
Methyl iodide is firstly used for reacting with Jinggang enzyme alcohol amine to obtain a crude product of N-methyl-Jinggang enzyme alcohol amine with the content of about 30 percent.
Collecting 1g crude product, adsorbing with 100ml 001 × 7 strong acid styrene cation exchange resin for half an hour, and adsorbing with 100ml H2O elution with 100ml MeOH/H2Eluting with 20% of O, then eluting with 100ml of pure MeOH, wherein the obtained pure MeOH eluent is mainly the target product N-methylvalienamine, and concentrating the obtained pure MeOH eluent to obtain the crude product of N-methyljingganganese alcohol amine with the purity of 85.56%.
And in the second step, HPLC preparation liquid phase separation is adopted, detection is carried out at 210nm, 10% methanol elution is carried out, a relatively pure target product eluent is separated, concentration and freeze-drying are carried out, and 205mg of N-methylwellsite alcohol amine with the content of 99.99% is obtained.
The nuclear magnetic hydrogen spectrogram, nuclear magnetic carbon spectrogram and mass spectrogram of the N-methyl well oil amine are shown in figures 1-3.
Example 3
Methyl iodide is firstly used for reacting with Jinggang enzyme alcohol amine to obtain a crude product of N-methyl-Jinggang enzyme alcohol amine with the content of about 30 percent.
1g of the crude product is taken and adsorbed for half an hour on 90ml of Dowex50 resin, and then 100ml of H is used2O elution with 100ml MeOH/H2Eluting with 20% of O, then eluting with 100ml of pure MeOH, wherein the obtained pure MeOH eluent is mainly the target product N-methylvalienamine, and concentrating the obtained pure MeOH eluent to obtain the crude product of N-methyljingganganese alcohol amine with the purity of 81.23%.
And secondly, preparing liquid phase by HPLC (high performance liquid chromatography), separating, detecting at 210nm, eluting with 20% methanol, separating a relatively pure target product eluent, concentrating, and freeze-drying to obtain 170mg of N-methylwellsite alcohol amine with the content of 99.38%.

Claims (4)

1. A refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine is characterized by comprising two steps of separation and purification:
(1) firstly using methyl iodide to react with Jinggang enzyme alcohol amine to obtain a crude product of N-methyl-Jinggang enzyme alcohol amine with the content of 30%, taking the crude product, firstly using 001 × 7 strong acid styrene cation exchange resin to adsorb the crude product, and then carrying out gradient elution, wherein the gradient elution process is H2O elution, MeOH/H2Elution with 20% O and pure MeOH gave H respectively2O elution MeOH/H2O ═ 20% elution and pure MeOH elution 3 eluates;
(2) concentrating the pure MeOH eluent in the step (1) to obtain an N-methyl-well-sentry enzyme alcohol amine crude product, preparing a liquid phase by adopting HPLC, detecting at 210nm, eluting by using a methanol aqueous solution, separating the eluent, concentrating and freeze-drying to obtain an N-methyl-well-sentry enzyme alcohol amine pure product.
2. The process for refining Voglibose impurity N-methyljinggangase alcohol amine according to claim 1, wherein in the step (2), the eluent for preparing the liquid phase is 5% methanol, 10% methanol or 20% methanol.
3. The refining process of voglibose impurity N-methyl wellsite hydramine according to claim 1, characterized in that the pure MeOH eluent in step (1) is concentrated by washing the remaining organic matters with methanol until no organic matters remain, and concentrating the methanol to obtain the crude product of N-methyl wellsite hydramine.
4. The refining process of Voglibose impurity N-methyl wellsite hydramine according to claim 1, characterized in that H2O eluent and MeOH/H2The O ═ 20% eluent was a mixture of trimethyl substituted product quaternary ammonium salt and dimethyl substituted product, and pure methanol eluent was the target product N-methylwellsite olamine.
CN201711475501.5A 2017-12-29 2017-12-29 Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine Active CN108059603B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711475501.5A CN108059603B (en) 2017-12-29 2017-12-29 Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711475501.5A CN108059603B (en) 2017-12-29 2017-12-29 Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine

Publications (2)

Publication Number Publication Date
CN108059603A CN108059603A (en) 2018-05-22
CN108059603B true CN108059603B (en) 2020-08-14

Family

ID=62140738

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711475501.5A Active CN108059603B (en) 2017-12-29 2017-12-29 Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine

Country Status (1)

Country Link
CN (1) CN108059603B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022187361A1 (en) * 2021-03-03 2022-09-09 Emergent Product Development Gaithersburg Inc. Valiolamine derivatives as glucosidase inhibitors

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350650A1 (en) * 1988-06-22 1990-01-17 Takeda Chemical Industries, Ltd. Therapeutic composition for hepatic encephalopathy
WO2004108657A1 (en) * 2003-06-11 2004-12-16 B T Gin., Inc. Preparation method of valienamine using solid catalysts
WO2006017975A1 (en) * 2004-08-16 2006-02-23 Shenzhen Taitai Pharmaceutical Industry Ltd. Preparation method of (+)-(1s, 2s, 3s, 4r, 5r)-1-amino-5-hydroxymethyl-n-2-(1, 3-dihydroxypropyl)-2, 3, 4-cyclohexanetriol
CN1861574A (en) * 2005-05-09 2006-11-15 上海三维制药有限公司 Purifying process of voigelibo saccharide
CN103588650A (en) * 2012-08-15 2014-02-19 中国医药集团总公司四川抗菌素工业研究所 High-purity voglibose and preparation method thereof
CN107501102A (en) * 2017-07-25 2017-12-22 浙江工业大学 A kind of preparation method of high-purity validamine

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350650A1 (en) * 1988-06-22 1990-01-17 Takeda Chemical Industries, Ltd. Therapeutic composition for hepatic encephalopathy
WO2004108657A1 (en) * 2003-06-11 2004-12-16 B T Gin., Inc. Preparation method of valienamine using solid catalysts
WO2006017975A1 (en) * 2004-08-16 2006-02-23 Shenzhen Taitai Pharmaceutical Industry Ltd. Preparation method of (+)-(1s, 2s, 3s, 4r, 5r)-1-amino-5-hydroxymethyl-n-2-(1, 3-dihydroxypropyl)-2, 3, 4-cyclohexanetriol
CN1861574A (en) * 2005-05-09 2006-11-15 上海三维制药有限公司 Purifying process of voigelibo saccharide
CN103588650A (en) * 2012-08-15 2014-02-19 中国医药集团总公司四川抗菌素工业研究所 High-purity voglibose and preparation method thereof
CN107501102A (en) * 2017-07-25 2017-12-22 浙江工业大学 A kind of preparation method of high-purity validamine

Also Published As

Publication number Publication date
CN108059603A (en) 2018-05-22

Similar Documents

Publication Publication Date Title
CN110283048B (en) Preparation method of cannabidiol crystal
CN106928323B (en) Preparation method of high-purity oritavancin key intermediate A82846B
CN106967137B (en) Method for separating high-purity oleuropein by liquid chromatography through macroporous resin combined preparation
CN108779147B (en) Reduced glutathione crystal and method for producing same
CN111675646B (en) Method for preparing 2-amino-3- (5-hydroxyindole) propionic acid by using gulonic acid crystallization mother liquor
CN109721632B (en) High-purity ganglioside GM1 and preparation method thereof
CN105334301B (en) Pyrrolo quinoline quinone (PQQ) disodium salt impurity separation and purification method
CN103694319B (en) A kind of purification process of Buserelin
CN106565425B (en) Method for recovering catechol and levodopa from levodopa mother liquor
CN108059603B (en) Refining process of Voglibose impurity N-methyl Jinggang enzyme alcohol amine
Liu et al. Isolation of α-arbutin from Xanthomonas CGMCC 1243 fermentation broth by macroporous resin adsorption chromatography
CN112159445B (en) Purification method and preparation method of beta-nicotinamide mononucleotide
CA2133644C (en) Process for making vancomycin
CN109400566B (en) Method for extracting and separating high-purity amentoflavone from Selaginella plant
CN107033114B (en) Method for separating and purifying dihydromyricetin
CN103936846B (en) A kind of purification process of protamine sulfate
CN106589075B (en) Purification method of teicoplanin
CN103910783B (en) A kind of preparation method of high-purity echinocandin B parent nucleus
CN102516340A (en) Method for separating and purifying hydroxycobalamin by using D150 macroporous resin
CN113248559B (en) Purification preparation method of siamenoside I
CN112724185A (en) Preparation method of gastrodin impurity
CN110240544A (en) A kind of chlorogenic acid method for extraction and purification and application
CN111154012A (en) Preparation method of ultra-high purity heparan sulfate
CN113698289B (en) Method for preparing shikimic acid from ginkgo leaf extraction waste liquid
CN109096273A (en) The method for separating and preparing of mezlocillin sodium impurity C, D and F

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant